As of 2025-09-18, the Relative Valuation of Iovance Biotherapeutics Inc (IOVA) is (16.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.22 USD, the upside of Iovance Biotherapeutics Inc based on Relative Valuation is -823.2%.
The range of the Relative Valuation is (15.41) - (16.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 15.5x | 14.9x |
| Forward P/E multiples | 14.2x - 15.6x | 14.9x |
| Fair Price | (15.41) - (16.70) | (16.06) |
| Upside | -794.1% - -852.4% | -823.2% |
| Date | P/E |
| 2025-09-12 | -2.11 |
| 2025-09-11 | -2.25 |
| 2025-09-10 | -2.21 |
| 2025-09-09 | -2.20 |
| 2025-09-08 | -2.21 |
| 2025-09-05 | -2.31 |
| 2025-09-04 | -2.04 |
| 2025-09-03 | -2.05 |
| 2025-09-02 | -2.03 |
| 2025-08-29 | -2.07 |
| 2025-08-28 | -2.07 |
| 2025-08-27 | -2.25 |
| 2025-08-26 | -2.27 |
| 2025-08-25 | -2.35 |
| 2025-08-22 | -2.50 |
| 2025-08-21 | -2.36 |
| 2025-08-20 | -2.35 |
| 2025-08-19 | -2.41 |
| 2025-08-18 | -2.32 |
| 2025-08-15 | -2.37 |
| 2025-08-14 | -2.27 |
| 2025-08-13 | -2.27 |
| 2025-08-12 | -2.07 |
| 2025-08-11 | -1.83 |
| 2025-08-08 | -1.96 |
| 2025-08-07 | -2.45 |
| 2025-08-06 | -2.39 |
| 2025-08-05 | -2.55 |
| 2025-08-04 | -2.63 |
| 2025-08-01 | -2.49 |
| 2025-07-31 | -2.38 |
| 2025-07-30 | -2.48 |
| 2025-07-29 | -2.71 |
| 2025-07-28 | -2.74 |
| 2025-07-25 | -2.90 |
| 2025-07-24 | -3.05 |
| 2025-07-23 | -3.68 |
| 2025-07-22 | -2.90 |
| 2025-07-21 | -2.31 |
| 2025-07-18 | -2.07 |
| 2025-07-17 | -2.17 |
| 2025-07-16 | -2.07 |
| 2025-07-15 | -1.80 |
| 2025-07-14 | -1.87 |
| 2025-07-11 | -1.74 |
| 2025-07-10 | -1.79 |
| 2025-07-09 | -1.85 |
| 2025-07-08 | -1.64 |
| 2025-07-07 | -1.58 |
| 2025-07-03 | -1.62 |